Showing results (141-150 of 401) with videos related to
Sort By:
Pageof 41
Frontiers in Pediatrics|February 11, 2022
Chimeric Antigen Receptor T-Cell Therapy in Paediatric B-Cell Precursor Acute Lymphoblastic Leukaemia: Curative Treatment Option or Bridge to Transplant?Jochen Buechner, Ignazio Caruana, Annette Künkele, et al.The Science of the Total Environment|May 8, 2010
Understanding consumption-related sucralose emissions - A conceptual approach combining substance-flow analysis with sampling analysisTina-Simone Schmid Neset, Heinz Singer, Philipp Longrée, et al.Scientific Reports|February 12, 2019
Molecular signature of human bone marrow-derived mesenchymal stromal cell subsetsSelim Kuçi, Zyrafete Kuçi, Richard Schäfer, et al.Current Stem Cell Research & Therapy|May 16, 2009
Adult stem cells as an alternative source of multipotential (pluripotential) cells in regenerative medicineSelim Kuçi, Zyrafete Kuçi, Hatixhe Latifi-Pupovci, et al.Frontiers in Pediatrics|September 30, 2016
Atypical Manifestation of LPS-Responsive Beige-Like Anchor Deficiency Syndrome as an Autoimmune Endocrine Disorder without Enteropathy and ImmunodeficiencyShahrzad Bakhtiar, Frank Ruemmele, Fabienne Charbit-Henrion, et al.Orphanet Journal of Rare Diseases|October 24, 2020
Revesz syndrome revisitedMichael Karremann, Eva Neumaier-Probst, Frank Schlichtenbrede, et al.Cancer Letters|May 26, 2004
Down-regulation of protein kinase Ceta by antisense oligonucleotides sensitises A549 lung cancer cells to vincristine and paclitaxelJürgen Sonnemann, Volker Gekeler, Katrin Ahlbrecht, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 27, 2018
Systematic Evaluation of Neurotoxicity in Children and Young Adults Undergoing CD22 Chimeric Antigen Receptor T-Cell TherapyHaneen Shalabi, Pamela L Wolters, Staci Martin, et al.Molecular Therapy. Advances|May 18, 2026
A single-cell multi-omics assay for simultaneous measurement of vector copy number and protein expression in CAR T cellsYilong Yang, Saurabh Parikh, Chieh-Yuan Li, et al.Frontiers in Immunology|March 23, 2017
The Smac Mimetic BV6 Improves NK Cell-Mediated Killing of Rhabdomyosarcoma Cells by Simultaneously Targeting Tumor and Effector CellsKyra Fischer, Sara Tognarelli, Stefanie Roesler, et al.Pageof 41